2018-08-01T12:53:49-05:00 2017-09-30 ERNST & YOUNG US LLP 200 CLARENDON STREET BOSTON MA 021165072 990 2016-10-01 042263040 Dana-Farber Cancer Institute Inc % STEVEN CONNOLLY DANA 6176323000 450 Brookline Avenue BP418 Boston MA 02215 MICHAEL RENEY CFO 6176323000 2018-07-30 true BARBARA E HUNT P00916443 6172662000 2018-07-17 2016 2022-09-23 18:48:47Z Laurie H Glimcher MD 450 BROOKLINE AVE Boston MA 02215 1499102536 false X www.dana-farber.org X 1951 MA The mission of DFCI is to provide expert, compassionate care to COMPASSIONATE CARE TO CHILDREN AND ADULTS WITH CANCER & ADVANCE THE TREATMENT, CURE, AND PREVENTION OF CANCER & RELATED DISEASES. 66 65 5849 5000 0 0 453735920 511844582 897271681 960793496 626175 1818484 24805170 20654663 1376438946 1495111225 3398992 4629223 0 0 449338575 497895456 3298849 2825453 34023447 888938258 1022889127 1344974674 1528239259 31464272 -33128034 2650084956 2599191879 1242255088 1067661784 1407829868 1531530095 THE MISSION OF DANA-FARBER CANCER INSTITUTE IS TO PROVIDE EXPERT, COMPASSIONATE CARE TO CHILDREN AND ADULTS WITH CANCER WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES. AS AN AFFILIATE OF HARVARD MEDICAL SCHOOL AND A COMPREHENSIVE CANCER CENTER DESIGNATED BY THE NATIONAL CANCER INSTITUTE, THE INSTITUTE ALSO PROVIDES TRAINING FOR NEW GENERATIONS OF PHYSICIANS AND SCIENTISTS, DESIGNS PROGRAMS THAT PROMOTE PUBLIC HEALTH PARTICULARLY AMONG HIGH-RISK AND UNDERSERVED POPULATIONS, AND DISSEMINATES INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES TO OUR TARGET COMMUNITY ACROSS THE UNITED STATES AND THROUGHOUT THE WORLD. false false 860948704 960793496 Clinical Care As one of the leading cancer centers in the world, Dana-Farber provides compassionate, comprehensive and personalized care to adults and children challenged with cancer, blood disorders and related diseases. In 2017, our expert clinicians and caregivers at our specialized treatment centers worked together to deliver the latest therapies to our patients through 328,591 outpatient MD visits and 165,792 infusion treatments. Since its founding in 1947 by Sidney Farber, MD, Dana-Farber has followed his vision for a cancer center that is just as dedicated to discoveries in cancer research as it is to delivering expert compassionate care. Dana-Farber is a founding member of Dana-Farber/Harvard Cancer Center and one of 49 NCI-designated Comprehensive Cancer Centers in the U.S. Dana-Farber is the only hospital ranked in the top four nationally by U.S News and World Report in both adult and pediatric cancer care. In 2017, we conducted 830 clinical trials, including therapeutic and non-therapeutic trials. 495303754 Research FDA Approvals: DFCI research in FY17 led to several FDA approvals including the revolutionary CAR T-cell therapy for adults with non-Hodgkin lymphoma; the first new drug for acute myeloid leukemia in 25 years; a novel drug for relapsed ovarian cancer; and an immunotherapy drug to treat relapsed Hodgkin lymphoma in adult and pediatric patients the first time that an immune checkpoint inhibitor has been approved to treat children with cancer. Personalized Cancer Vaccines: DFCI researchers developed a personalized neoantigen-based vaccine that induced complete remission from advanced melanoma for all patients in a phase 1 trial, either from the vaccine alone or in combination with another immunotherapy, providing proof of principle that a personal vaccine tailored to a patients tumor can be produced and can generate a potent and highly specific response. Improving Survival: Among patients with stage III colon cancer, a multi-institution study led by DFCI showed that eating tree nuts twice a week was associated with significantly reduced risk of recurrence and mortality. Predicting Response: DFCI scientists found that a protein whose function was previously unknown plays a key role in managing DNA repair, showing promise as a potential drug target and a potential tool to help identify cancer patients who can benefit from particular drugs. Preventive Immunotherapy: DFCI researchers demonstrated that early intervention with an immunotherapy-based drug combination may prevent progression of high-risk smoldering multiple myeloma to the full-blown disease. Targeting Aggressive Cancers: A DFCI study of a combination of two drugs targeting molecular pathways controlled by the RAS oncogene achieved long-term clinical benefit in patients with RAS-driven lung, ovarian, and thyroid cancers, which are aggressive and difficult to treat. Precision Medicine for Pediatric Patients: In the largest clinical study to date of genetic abnormalities in pediatric brain tumors, DFCI researchers found that a majority of the tumors tested had genetic irregularities that could influence diagnosis or potentially be treated with approved drugs or agents being evaluated in clinical trials. Identifying Cancer Risk: DFCI researchers developed and launched a simple online assessment tool that can help rapidly identify people who should undergo genetic testing for Lynch syndrome, an inherited disorder that greatly increases the lifetime risk of colorectal, endometrial, ovarian, stomach, and other cancers. 22319691 4629223 COMMUNITY BENEFITS The role of Dana-Farber's Community Benefits office is to support the Institute's goal to reduce cancer risk among medically underserved populations. To that end, we work with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancer control. We are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, skin, and prostate cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening, and clinical trials; and strengthen the support system for medically underserved populations. In short, we are committed to making Dana-Farber's care and research findings are more accessible to everyone within and outside its walls. In FY 2017: Dana-Farbers Mammography Services provided close to 2,500 mammograms on the van and at the mammography suite in Roxbury. 1,166 individuals received breast health education on the mammography van or at a community outreach event. A total of 43 community members have been trained as Lay Health Advisors in breast cancer, screening guidelines, and health promotion and outreach strategies. 1,475 community members were reached through Sun Safety Education and Screening events, with an average of 60 participants per event. A total of 3,444 individuals were reached through 146 community education, outreach and screening events. 1378572149 true true false true false false false false false true true false false true true false false true false false true false false true true false true true true true true true false false false false false true false false false false true false false false false true true true true false true 625 0 true 5849 true false true CJ false false false true true false false false false X 66 65 true false false false false false false true true false false true true true true true true true true false AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X STEVEN CONNOLLY 6176323000 C/O DFCI 450 BROOKLINE AVE BP418 Boston MA 02215 Alexander Susan Trustee 1.0 0.0 X 0 0 0 Bekenstein Joshua Trustee & Chairman 2.0 0.0 X X 0 0 0 Berkowitz Roger Trustee 1.0 0.0 X 0 0 0 Berylson Amy Trustee 1.0 0.0 X 0 0 0 Blum Betty Ann Trustee 1.0 0.0 X 0 0 0 Brock-Wilson Jane Trustee 1.0 0.0 X 0 0 0 Champa Michael Trustee 1.0 0.0 X 0 0 0 Chandra Monica Trustee 1.0 0.0 X 0 0 0 Cox Howard Trustee 1.0 0.0 X 0 0 0 Curtin Neal Trustee & Secretary 2.0 0.0 X X 0 0 0 Daley Karen Trustee 1.0 0.0 X 0 0 0 DaSilva Kevin Trustee 1.0 0.0 X 0 0 0 Dobson Sean Trustee 1.0 0.0 X 0 0 0 Farrington Thomas Trustee 1.0 0.0 X 0 0 0 Fine Stephen Trustee 1.0 0.0 X 0 0 0 First Deborah Trustee 1.0 0.0 X 0 0 0 Foulkes Helena Trustee 1.0 0.0 X 0 0 0 Gibson Nancy Trustee 1.0 0.0 X 0 0 0 Glimcher Laurie Trustee, President and CEO 42.0 8.0 X X 660218 8654 230873 Greenthal Jill Trustee 1.0 0.0 X 0 0 0 Gross Phillip Trustee 1.0 0.0 X 0 0 0 Hadley Christopher Trustee 1.0 0.0 X 0 0 0 Heller Frances Trustee 1.0 0.0 X 0 0 0 Jaffe Alison Poorvu Trustee 1.0 0.0 X 0 0 0 Jamieson Jane Trustee 1.0 0.0 X 0 0 0 Janower Andrew Trustee 1.0 0.0 X 0 0 0 Kafker Hon Scott Trustee 1.0 0.0 X 0 0 0 Knez Brian Trustee & Treasurer 2.0 0.0 X X 0 0 0 Koppel Steven Trustee 1.0 0.0 X 0 0 0 Koster Stephen Trustee 1.0 0.0 X 0 0 0 Kraft Robert Trustee 1.0 0.0 X 0 0 0 Kyle Amy Trustee 1.0 0.0 X 0 0 0 LaTorre James Trustee 1.0 0.0 X 0 0 0 Lubin Richard Trustee & Vice-Chairman 2.0 0.0 X X 0 0 0 Lucas Bradley Trustee 1.0 0.0 X 0 0 0 Lucchino Lawrence Trustee 1.0 0.0 X 0 0 0 Marcus Paul Trustee 1.0 0.0 X 0 0 0 Martin Demond Trustee 1.0 0.0 X 0 0 0 McCain Tracey Trustee 1.0 0.0 X 0 0 0 Medel MD Roger Trustee 1.0 0.0 X 0 0 0 Norberg Joseph Trustee 1.0 0.0 X 0 0 0 O'Connor John Trustee 1.0 0.0 X 0 0 0 Owens Edward Trustee 1.0 0.0 X 0 0 0 Packman Karen Linde Trustee 1.0 0.0 X 0 0 0 Palandjian Peter Trustee 1.0 0.0 X 0 0 0 Pasquarello Theodore Trustee 1.0 0.0 X 0 0 0 Perini Jennifer Trustee 1.0 0.0 X 0 0 0 Perlmutter Steven Trustee 1.0 0.0 X 0 0 0 Poduska Susan Trustee 1.0 0.0 X 0 0 0 Reynolds Robert Trustee 1.0 0.0 X 0 0 0 Rosenthal Harvey Trustee 1.0 0.0 X 0 0 0 Sachs Robert Trustee 1.0 0.0 X 0 0 0 Sanders Rebecca Trustee 1.0 0.0 X 0 0 0 Schlager Eric Trustee 1.0 0.0 X 0 0 0 Sen Laura Trustee 1.0 0.0 X 0 0 0 Socol Jerry Trustee 1.0 0.0 X 0 0 0 Stansky Robert Trustee 1.0 0.0 X 0 0 0 Stratford Sandra Trustee 1.0 0.0 X 0 0 0 Sullivan Ronald Trustee 1.0 0.0 X 0 0 0 Tempel Jean Trustee 1.0 0.0 X 0 0 0 Terrana Beth Trustee 1.0 0.0 X 0 0 0 Ting David Trustee 1.0 0.0 X 0 0 0 Tocio Mary Ann Trustee 1.0 0.0 X 0 0 0 Williams Frederica Trustee 1.0 0.0 X 0 0 0 Yeshwant Krishna Trustee 1.0 0.0 X 0 0 0 Yost George Trustee 1.0 0.0 X 0 0 0 Boskey Richard S ESQ General Counsel & Asst. Sec. 50.0 0.0 X 594248 0 62865 Puhy Dorothy Coo & EVP 50.0 0.0 X 877448 0 44099 Reney Michael CFO & Asst. Treasurer 50.0 0.0 X 591149 0 5486 Bartel Sylvia R Ph MHP VP of Pharmacy Services 50.0 0.0 X 254322 0 63670 Bunnell Craig A MD MBA MPH Chief Medical Officer 50.0 0.0 X 667903 0 42658 Gettleman Wendy VP of Facilities Management 50.0 0.0 X 266233 0 54536 Griffin James D MD Chair of Med Oncology 50.0 0.0 X 706951 0 55647 Johnson Bruce MD Chief Clinical Research Office 50.0 0.0 X 622788 0 55032 Megdal Maria SVP of Institute Operations 50.0 0.0 X 440033 0 54496 Memmott Drew SVP Research Administration 50.0 0.0 X 436253 0 61514 Paresky Susan SVP of Development 50.0 0.0 X 689553 0 55409 Rollins Barrett J MD PHD Chief Scientific Officer 50.0 0.0 X 662404 0 54715 Anderson Kenneth MD Director, Myeloma Therapeutics 50.0 0.0 X 593785 0 58062 Constantine Michael MD Milford Med Dir-Hematology 50.0 0.0 X 678281 0 51136 Nadler Lee MD SVP for Experimental Medicine 50.0 0.0 X 694678 0 63504 Soiffer Robert MD Chief of Hemotologic Malig. 50.0 0.0 X 581917 0 61115 Winer Eric MD Chief of Div of Women's Cancer 50.0 0.0 X 762437 0 59611 Benz Edward J JR MD Former Officer 42.0 8.0 X 1330022 25489 147710 Bird Karen Former Officer 50.0 0.0 X 373623 0 27808 Reid-Ponte Patricia Former Key Employee 50.0 0.0 X 446524 0 53124 Stone Richard M MD Former Key Employee 50.0 0.0 X 456067 0 63886 Sallan Stephen E MD Former Key Employee 50.0 0.0 X 533869 0 62384 13920706 34143 1489340 1093 true true false Partners Healthcare System Inc PO Box 3715 BOSTON MA 02241 Information Systems 88087192 Brigham and Women's Physicians Org 111 Cypress Street BROOKLINE MA 02445 Medical Services 67675102 Bond Brothers 10 Cabot Road Suit 300 MEDFORD MA 02155 Construction 38329329 arendcr longwood llc 2310 Washington st NEWTON MA 02462 rent 21593916 South Shore Hospital 55 fogg rd SOUTH WEYMOUTH MA 02190 Medical Services 19408641 474 271305 24725695 138616007 348231575 16432895 511844582 NET PATIENT SERVICE REVENUE 621110 960793496 960793496 960793496 1818484 1818484 0 3260694 3260694 4172425 4172425 0 4172425 4172425 0 991984 24725695 3991311 -2999327 -2999327 0 0 0 0 0 0 PARKING LOT REVENUE 812930 5812589 5812589 FOOD SERVICE REVENUE 722210 3909861 3909861 WCB BOUTIQUE INCOME 446199 1118481 1118481 5379940 5379940 16220871 1495111225 960793496 22473147 3272816 3272816 1356407 1356407 0 0 7934224 3370435 3874236 689553 2709527 980393 1729134 394465726 337634618 35594257 21236851 25905452 21868873 2634456 1402123 38440738 32450914 3909233 2080591 28439789 24008310 2892186 1539293 8311296 4334778 3976518 11047526 7535882 3499770 11874 1147165 1147165 406953 406953 2825453 2825453 0 165480548 144761044 20386750 332754 4351427 2348205 728200 1275022 30005145 24153873 4899221 952051 59576289 58383521 1141164 51604 0 97452028 81907464 15536063 8501 9985248 8991456 909553 84239 0 3490271 1799856 752605 937810 28708198 28708198 0 96629150 93528624 3100526 5079135 134657 4944478 OTHER PATIENT CARE EXPENSES 28337058 28337058 MISCELLANEOUS 50761949 46178073 3988148 595728 MEDICAL SUPPLIES EXPENSE 418087545 418087545 BAD DEBT EXPENSE 4032196 4032196 1528239259 1378572149 115643663 34023447 0 0 121534265 112831937 45149193 44473370 122716623 110362614 471541 720707 0 0 0 0 17576865 21750551 28683570 30981820 1696074402 731887849 921354109 964186553 0 0 0 0 0 0 7894580 7894580 1384704210 1305989747 2650084956 2599191879 144561001 142737917 0 0 0 0 545302107 539978780 0 0 0 0 251483327 74174396 0 0 300908653 310770691 1242255088 1067661784 X 682684757 725849905 540174357 612694419 184970754 192985771 1407829868 1531530095 2650084956 2599191879 X -33128034 156828261 X false true X true true true X 393393949 403408212 427883303 453735920 511844582 2190265966 0 0 393393949 403408212 427883303 453735920 511844582 2190265966 0 2190265966 12285983 30943986 17299053 13734456 9251603 83515081 0 14090598 15163484 14345239 15146613 17212855 75958789 2349739836 3916596106 0.93213 0.93053 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true false true false true 251715 true 155238 false false 406953 false Schedule C Part II-B VAN SCOYOC - provided federal legislative consulting to DFCI. MCDERMOTT, QUILTY & MILLER, LLP - provided state legislative and government relations consulting on health interests to DFCI.CONFERENCE OF BOSTON TEACHING HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. CQ Roll Call is a service vendor that provides grassroots advocacy software used for emails and action alerts on advocacy issues. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION AND THE MASSACHUSETTS HOSPITAL ASSOCIATION, NOT-FOR-PROFIT ORGANIZATIONS THAT REPRESENT AND ADVOCATE FOR THE COLLECTIVE INTERESTS OF THEIR MEMBER HOSPITALS AND HEALTH SYSTEMS THROUGH LEADERSHIP IN PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. A PORTION OF THE MEMBERSHIP DUES TO THESE ORGANIZATIONS ARE USED FOR LOBBYING ACTIVITIES. On occasion, DFCI executive leadership meet with state and federal elected officials to advocate for the passage of legislation and funding to advance cancer research and treatment, and legislation to support services for cancer patients and cancer survivors. In addition, DFCI submits letters and/or testimony to elected officials and policy makers on these issues. 252162000 9815000 32600000 18329000 276248000 238449000 10151000 20243000 16681000 252162000 250650000 7603000 -4102000 15702000 238449000 231119000 11556000 22937000 14962000 250650000 207975000 9214000 27582000 13652000 231119000 0.70000 0.30000 false true true 7640445 7640445 1134794310 416733075 718061236 127883622 74989362 52894260 382975202 240165413 142809789 42780823 42780823 964186553 INTEREST IN DANA-FARBER, INC. 1186616680 MISCELLANEOUS ASSETS 92388234 INT IN DANA-FARBER CANCER CARE 26984833 1305989747 0 AMOUNTS DUE TO 3RD PARTY PAYOR 42715923 RESEARCH ADVANCES 95979000 PROV FOR MED MALPRACTICE CLAIM 1292000 SWAP VALUATION LIABILITY 46255234 MISCELLANEOUS LIABILITIES 124528534 310770691 Schedule D, Part V, Question 4 Dana-Farber, Inc. (DFI) a related organization of Dana-Farber Cancer Institute, Inc. (DFCI) holds the endowments for DFCI and therefore reports the endowment funds on DFI's 990 accordingly. As described in detail in the Consolidated Audited Financial Statements, the Institute's endowments consist of numerous individual funds established for a variety of purposes. These endowments consist solely of donor-restricted endowment funds. As required by Generally Accepted Accounting Principles, net assets associated with endowment funds are classified and reported based on the existence or absence of donor-imposed restrictions. All uses of the organization's endowment funds are directly related to the Institute's exempt mission and purposes. Central America and the Caribbean Program Services Research and Education 47160 Central America and the Caribbean Program Services Subcontracted Research 32847 Central America and the Caribbean Program Services Jointly owned for ins 3725773 East Asia and the Pacific Program Services Subcontracted Research 1058973 East Asia and the Pacific Program Services Research and Education 188693 Europe (Including Iceland and Greenland) Program Services Subcontracted Research 1093673 Middle East and North Africa Program Services Subcontracted Research 99590 North America Program Services Sucontracted Research 758807 North America Program Services Research and Education 169447 South Asia Program Services Sucontracted Research 458059 Sub-Saharan Africa Program Services Subcontracted Research 760330 South America Program Services Research and Education 247070 8640422 8640422 true false true false false false X X X X X X X true TRUESENSE MARKETING Direct Mail Consulting false 11823003 2825453 8997550 11823003 2825453 8997550 All States BMJW Walk 9331129 9137000 194129 228632 15540 2700 1186650 DF Marathon chl 6087027 5965158 121869 161356 8945 570617 15 10299523 9623537 675986 296941 375771 294244 849915 25717679 24725695 991984 686929 400256 296944 2607182 3991311 -2999327 true true X true true X true true true false true true 13396535 6163421 7233114 0.00480 68079954 51316395 16763559 0.01100 81476489 57479816 23996673 0.01580 4888958 4888958 0.00320 5712549 428139 5284410 0.00350 551677514 432959534 118717980 0.07780 1274642 1274642 0.00080 563553663 433387673 130165990 0.08530 645030152 490867489 154162663 0.10110 663347 663347 0.00040 470500 470500 0.00030 1133847 1133847 0.00070 true 4032196 40322 229782800 242626131 -12843331 true true 1 1 DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVE BOSTON MA 02215 www.dana-farber.org 2335 X X X D-F/BWH @ Milford, and SOUTH Shore D-F @ st elizabeth's DANA-FARBER CANCER INSTITUTE INC 1 false false true X X X X X X X X X 15 true false false true X dana-farber.org X true 15 true dana-farber.org false true X 133. 300. X true true X X X true X dana-farber.org/PFA X dana-farber.org/PFA X dana-farber.org/PFA X X X X X X true X false X X X true X false false Part V Part V, Line 5 Dana-Farber Cancer Institute contracted Health Resources in Action (HRiA), a non-profit public health organization, to conduct the most recent 2016 (Tax Year 2015) community health needs assessment. The CHNA assessment was guided by a participatory, collaborative approach, integrating existing secondary data on social, economic, and health issues in the region with qualitative information from three focus groups with community residents and fifteen interviews with community stakeholders from March 2016 through June 2016. Overall this process engaged over 150 people. Focus groups were held with 39 community residents drawn from the region representing English-speaking adult cancer survivors, Spanish-speaking adult cancer survivors and community members residing in DFCI priority neighborhoods. Additionally, a total of 22 individuals representing the DFCI community as well as the region at large were engaged in key informant and group discussions. Key informants represented a number of sectors including academic research, health care, public health, social service, and city government. Discussions explored participants perceptions of their communities, priority health concerns, perceptions of cancer and related services across the cancer continuum (prevention, screening, treatment, survivorship), and suggestions for future services and resources to address these issues. A semi-structured moderators guide was used across all discussions to ensure consistency in the topics covered. Participants for the focus groups were recruited by Health Resources in Action, YMCA of Dorchester, the Dana-Farber/Harvard Cancer Center, and Dana-Farber Cancer Institute. It was also a priority to recruit adults from traditionally underserved populations, including the low-income and those who do not speak English as a primary language. In addition to the primary data collection, Conference of Boston Teaching Hospitals (COBTH), of which DFCI is an active member, partnered with the Boston Alliance of Community Health (BACH), the city-wide coalition comprised of neighborhood coalitions, to conduct three focus groups with community residents in early Spring 2016 delving into peoples experiences with the social determinants of health. A total of over 80 community residents participated. The outputs of the neighborhood-level meetings are included in the findings of Dana-Farbers 2016 CHNA and reflect the commitment of Dana-Farber and other COBTH member hospitals to work together in addressing the social, economic, and environmental factors that impact health, well-being, and more specifically, cancer outcomes in our surrounding communities. Additionally, four separate groups were engaged in June 2016 to discuss the CHNAs preliminary data findings. In these sessions, HRiA presented key qualitative and quantitative findings in a 45-minute presentation each to the following DFCI committees: External Advisory Committee, Board of Trustees Community Programs Committee, Internal Community Benefits Committee, and Community Benefits Office staff. A total of 38 individuals were engaged in this process including Gerry Thomas, Director, Community Initiatives Bureau, and Monica Valdez Lupi, Executive Director both from the Boston Public Health Commission. Part V, Line 7a DFCIs Community Health Needs Assessment Report is available on the DFCI Website at http://www.dana-farber.org/About-Us/Community-Outreach/Community-Health-Ne eds-Assessment-Reporting.aspx Part V, Line 10a DFCI's implementation strategy is available on the DFCI website. http://www.dana-farber.org/uploadedFiles/Library/about-us/community-outrea ch/chna-implementation-plan.pdf Part V, Line 11 Dana-Farber Cancer Institute addressed all the needs identified in the Community Health Needs Assessment and the accompanying Implementation Plans. A full description of our programs is available on our website both in the Community Health Needs Assessment Report and in the Community Health Implementation Plan. While our expertise as a comprehensive cancer center leads us to focus largely on reducing cancer incidence and mortality among medically underserved populations through our clinical community screening and outreach programs that include mobile mammography and breast health education, skin cancer education and screening, HPV education and vaccination, tobacco cessation and increasing awareness about survivorship in communities of color, we recognize that our priority neighborhoods are also dealing disproportionately with challenging situations related to social and economic factors such as limited employment opportunities, substance abuse and opioid addiction, low education levels, lack of affordable housing, and community violence, among others. We work on these broader issues by advocating and by partnering with local coalitions and community based organizations such as Boston Alliance for Community Health and member organizations. Part V Line 13h In addition to determining eligibility for discounted care based on family income, DFCI offers assistance to patients who have excessive medical bills (exceeding 30-40% of family income). Part V Line 22 Depending on a patient's financial situation, FAP-eligible patients were charged 0% to 30% of billed charges, which was not more than the AGB. In FY17, DFCI determined AGB on an annual basis using the "look-back method," described under Treasury Regulation Section 1.501(r)-5(b)(1). Specifically, DFCI's annual AGB percentage was equal to the sum of all gross charges during the prior fiscal year divided by Claims Paid in connection with those charges. For purposes of the AGB calculation, Claims Paid included claims for emergency and medically necessary care paid by both Medicare fee-for-service and all private health insurers as primary payers, together with any associated portions of these claims paid by Medicare beneficiaries or insured individuals in the form of co-payments, co-insurance or deductibles. 1 DANA-FARBERNHOH ELLIOTT MED CENTER 40 BUTTRICK RD LONDONDERRY NH 03053 MED ONCOLOGY & INFUSION UNIT Part I Part I, Line 3c In addition to determining eligibility for discounted care based on family income, DFCI offers assistance to patients who have excessive medical bills (exceeding 30-40% of family income).Part I, Line 6a The community benefit report was completed by DFCI and is annually provided to the Massachusetts Attorney General's office, where it is then made public on its website. Part I, Line 7 DFCI's State Cost Report was used to develop the Institutes cost to charge ratio that was applied to charity care charges to determine the cost of financial assistance cost (Line 7a). Line 7b reflects the specific loss incurred for the Institute's Medicaid activity. The Institution is a preeminent provider of heath training to health professionals who desire training in the skills necessary to treat cancer patients. The institution trains physicians, scientists, medical students and individuals looking to create a career in the field of cancer. The amounts reported as health training represent costs in excess of amounts reimbursed by third party payers such as training grant revenues and direct medical education payments from the Medicare Program. Department leaders submit expenditures to community benefits along with a description of the services provided to medically underserved populations. Line 7f expenditures are reviewed by leadership and in partnership with DFCIs office of Finance, the expenditures are approved. The amounts are captured in three buckets- CB expenditures( all programs); Leveraged Funds (those funds supported in full or part through grants/donation) and Community Sponsorships. Part II Part II, Line 1 Physical Improvements and housing-DFCI provides a limited number of low cost rooms that serve as a home away from home for oncology patients and their families while they are receiving treatment. Part II, Line 8 To encourage underrepresented students of color to explore and pursue careers in health and science, Dana-Farber maintains educational partnerships with Boston area high schools and colleges. During Academic Year 2016-2017, 22 students participated in a college and career readiness training program. An additional 40 students were enrolled during the summer for a total of 60 student interns. Eligible students either attended or graduated from Boston Public Schools. During the 7-week summer program, students interned 30-hours per week and participated in college tours and career readiness workshops. Part III Section A, Line 3 The amount of Bad Debt attributed to financial assistance patients is based on actual writeoffs. The Bad Debt amount should be treated as a community benefit as it is similar to Unreimbursed Financial Assistance, as reported and allowed (Part I Line 7a), but for a different population. Part III Line 2 and Line 4 The amount of Bad Debt of $4,032,196 comes directly from our General Ledger and is based on Bad Debt activity consistent with Generally Accepted Accounting Principles (GAAP). The Bad Debt Footnote is found on Audited Financial Statements Pages 12 & 13 Part III Line 8 The Medicare cost on line 6 comes from the Medicare cost report and is based on Medicares cost finding principles and methodologies. We strongly believe that the entire amount of the shortfall of $12,843,331 should be treated as a community benefit as this represents the Institutes commitment to the elderly and disabled community by providing services that are not reimbursed. Part III Line 9b Within DFCI's credit and collections policy there are provisions that describe collection practices to be followed for patients who are known to qualify for charity care or financial assistance in accordance with federal and Massachusetts law. Part V Part V, Section A DFCI main campus is at 450 Brookline Ave., Boston, MA. DFCI's satellite locations (below) each operate under the same hospital license. Dana-Farber at Milford Regional Medical Center 20 Prospect Street, Milford, MA 01757; Dana-Farber at South Shore 101 Columbian Street, South Weymouth, MA 02190; and Dana-Farber at Steward St. Elizabeth;s Medical Center 736 Cambridge Street, Cushing Pavilion, 5th Floor, Brighton MA 02135 Part VI Part VI, Line 2 Needs Assessment Dana-Farber Cancer Institute continuously assesses the community needs through our participation in community coalitions, task forces, working groups and direct communication with the community residents that serve on our external advisory committee and in our patient and family advisory board. A full description of our community engagement process can be found on our website both in the Community Health Needs Assessment Report and in the Community Health Implementation Plan. Part VI, Line 3 DFCI is committed to offering financial assistance to eligible Patients who do not have the ability to pay for their medical services in whole or in part. In order to accomplish this charitable goal, DFCI widely publicizes its Patient Financial Assistance (PFA) Policy within its facilities, in direct communications with Patients and in the communities that it services, particularly in the communities with the greatest unmet health needs. The PFA Policy, a plain language PFA summary and the PFA application are posted on DFCIs website in English and Spanish. In addition, information about the PFA is provided to all patients at Registration and/or Admission, and is available upon request, without charge, through a DFCI Financial Counselor, Customer Service Representative, or by mail. Following care, all billing statements sent to a patient indicate how the patient can obtain information about the PFA Policy. In collaboration with DFCIs community partners, information about the FAP is shared with residents of DFCIs priority neighborhoods. Efforts to notify community members most likely to require assistance include distributing plain language summaries of this Policy to local community health centers and other non-profit organizations. Part VI, Line 4 DFCI serves the community of Eastern Massachusetts and New England, including the communities surrounding its primary location in Boston and its satellite locations in Milford, Massachusetts, Weymouth, Massachusetts, Brighton, Massachusetts and Londonderry, New Hampshire. DFCIs community includes adults and children with cancer or at risk of developing cancer, and their families. DFCI focuses its community outreach efforts on its priority Boston neighborhoods of Roxbury, Mission Hill, Dorchester, Mattapan and Jamaica Plain (which collectively comprise 39% of Boston's overall population). Two of Bostons most populated neighborhoods are DFCIs priority neighborhoods Dorchester with 122,598 residents, followed by Roxbury with 49,028. White residents now make up less than half of the citys racial and ethnic composition (46%). Black or African American residents were the second largest racial and ethnic group (23%), followed by Hispanics (18%) and Asians (9%). There is substantial variation in the racial and ethnic diversity by DFCI priority neighborhood, with nearly three-quarters of Mattapan residents and half of Roxbury residents identifying as Black or African American. Among DFCI priority neighborhoods, Roxbury and Jamaica Plain have the largest Hispanic populations with 29% and 24% respectively, while Mission Hill and Dorchester have the largest Asian populations among the priority neighborhoods with 14% and 10% respectively. The median incomes of DFCIs priority communities are generally much lower than Boston overall, with Roxbury at a median income of $25,254, Mission Hill at $35,020, and Mattapan at $42,206. Many of DFCIs priority neighborhoods, Roxbury and Mattapan, which are more likely to have a greater population at the lower end of the income spectrum. Residents in DFCIs priority neighborhoods appear to experience higher rates of poverty than Boston overall. Female headed households are especially vulnerable, with 45% of Roxbury female-headed households living below the poverty line. Part VI, Line 5 Dana-Farbers 2016 Community Health Needs Assessment and Implementation Plan provide a robust description of our comprehensive cancer control programs and services. The report also provides a summary of accomplishments from our last needs assessment and sets forth our commitment to addressing the new opportunities to reduce the cancer burden in medically underserved communities in Boston. The reports can be found at http://www.dana-farber.org/About-Us/Community-Outreach/Community-Health-Ne eds-Assessment-Reporting.aspx. In addition, DFCI furthers its exempt purpose by promoting the health of the community through devoting the vast majority of its surplus funds to Institutional Supported Research (119 million), by providing financial assistance to patients unable to afford care and by maintaining a community board. Part VI, Line 7 State Filing of Community Benefit Report Massachusetts true AMERICAN CANCER SOCIETYTOBACCO FREE MA 250 Williams ST NW Atlanta GA 30303 131788491 501(C)(3) 8000 CANCER RES AND DEVLP FENWAY HIGH SCHOOL 174 Ipswich Street Boston MA 02215 046719813 501(C)(3) 20000 community support Friend's of Dana-Farber 450 Brookline Ave BOSTON MA 02215 371613621 501(C)(3) 50000 CANCER RES and devlp LEUKEMIA & LYMPHOMA SOCIETY 1311 Mamaroneck White Plains NY 10605 135644916 501(C)(3) 40000 CANCER REs and devlp MADISON PARK DEVELOPMENT CORPORATION 184 Dudley St Roxbury MA 02119 237164223 501(C)(3) 20000 community support PROSTATE HEALTH EDUCATION NETWORK INC 500 Victory Rd 4th Fl Quincy MA 02453 331042404 501(C)(3) 30000 CANCER RES and devlp THE BREAST CANCER RESEARCH FOUNDATION 60 East 56th 8th FL New York NY 10022 133727250 501(C)(3) 10000 Cancer Res and devlp UNITED WAY OF MASSACHUSETTS BAY 51 Sleeper St Boston MA 02210 042382233 501(C)(3) 10000 Cancer Res and devlp WHITTIER STREET HEALTH CENTER 1290 Tremont St Roxbury MA 02120 042619517 501(C)(3) 159270 Cancer Res and devlp Harvard University 60 Oxford Street Cambridge MA 02138 042103580 501(c)(3) 2732864 Cancer Res and devlp Boston Private Industry Council 2 Oliver St Boston MA 02109 042676661 501(c)(3) 27500 community support Boston Ronald McDonald House 229 Kent St Brookline MA 02446 042627411 501(c)(3) 9000 Provides Housing Camp Harbor View Foundation 200 Clarendon St 60th FL Boston MA 02116 753235491 501(c)(3) 10000 Community Support Peer Health Exchange 70 Gold Street San Fransisco CA 94133 562374305 501(c)(3) 10000 cancer res and devlp 14 0 Patient Assistance 94 65672 Patient Asst Patient Assistance 2287 1290735 FMV Patient Asst Part IV All grants and donations were given to 501(c)(3) organizations to fulfill their missions. X false true X X X X X false true false false false false false true false Glimcher Laurie Trustee, President and CEO 369223 8654 250000 0 40995 0 227500 0 3373 0 891091 8654 0 0 Boskey Richard S ESQ General Counsel & Asst. Sec. 475132 0 81626 0 37490 0 37800 0 25065 0 657113 0 0 0 Puhy Dorothy Coo & EVP 649330 0 165607 0 62511 0 37800 0 6299 0 921547 0 0 0 Reney Michael CFO & Asst. Treasurer 523990 0 0 0 67159 0 0 0 5486 0 596635 0 0 0 Bartel Sylvia R Ph MHP VP of Pharmacy Services 231336 0 21373 0 1613 0 33870 0 29800 0 317992 0 0 0 Bunnell Craig A MD MBA MPH Chief Medical Officer 533521 0 98658 0 35724 0 37800 0 4858 0 710561 0 0 0 Gettleman Wendy VP of Facilities Management 244091 0 21233 0 909 0 25692 0 28844 0 320769 0 0 0 Griffin James D MD Chair of Med Oncology 559095 0 97823 0 50033 0 37800 0 17847 0 762598 0 0 0 Johnson Bruce MD Chief Clinical Research Office 482126 0 92674 0 47988 0 36222 0 18810 0 677820 0 0 0 Megdal Maria SVP of Institute Operations 363703 0 62480 0 13850 0 37800 0 16696 0 494529 0 0 0 Memmott Drew SVP Research Administration 351475 0 61074 0 23704 0 37800 0 23714 0 497767 0 0 0 Paresky Susan SVP of Development 545699 0 90860 0 52994 0 37800 0 17609 0 744962 0 0 0 Rollins Barrett J MD PHD Chief Scientific Officer 529880 0 92793 0 39731 0 37800 0 16915 0 717119 0 0 0 Stone Richard M MD Former Key Employee 397519 0 31608 0 26940 0 37800 0 26086 0 519953 0 0 0 Anderson Kenneth MD Director, Myeloma Therapeutics 527533 0 5693 0 60559 0 37800 0 20262 0 651847 0 0 0 Constantine Michael MD Milford Med Dir-Hematology 585187 0 47978 0 45116 0 24550 0 26586 0 729417 0 0 0 Nadler Lee MD SVP for Experimental Medicine 546729 0 98241 0 49708 0 37800 0 25704 0 758182 0 0 0 Soiffer Robert MD Chief of Hemotologic Malig. 510329 0 26429 0 45159 0 37800 0 23315 0 643032 0 0 0 Winer Eric MD Chief of Div of Women's Cancer 512327 0 105006 0 145104 0 42800 0 16811 0 822048 0 15000 0 Benz Edward J JR MD Former Officer 905176 25489 323612 0 101234 0 132493 0 15217 0 1477732 25489 0 0 Bird Karen Former Officer 315328 0 55440 0 2855 0 0 0 27808 0 401431 0 0 0 Reid-Ponte Patricia Former Key Employee 364623 0 64403 0 17498 0 37800 0 15324 0 499648 0 0 0 Sallan Stephen E MD Former Key Employee 425337 0 76089 0 32443 0 37800 0 24584 0 596253 0 0 0 Schedule J, Part 1, Line 4b The following individuals participate in DFCI's 457(f) plan; taxable amounts are included in reportable compensation in Schedule J, Part II, Column (B)(iii): Anderson, Kenneth, MD 33,484 Benz, Edward J. Jr., MD 83,518 Boskey, Richard S., ESQ 27,211 Bunnell, Craig A. MD 33,650 Constantine, Michael, MD 40,795 Griffin, James D., MD 37,394 Johnson, Bruce MD 27,699 Megdal, Maria 12,944 Memmott, Drew 22,360 Nadler, Lee, MD 36,974 Paresky, Susan 35,698 Puhy, Dorothy 48,483 Reid-Ponte, Pat 13,302 Rollins, Barrett J., MD, PHD 33,767 Sallan, Stephen E., MD 21,726 Soiffer, Robert J., MD 32,162 Stone, Richard M MD 17,613 Winer, Eric, MD 32,163 Membership Dues Dues DFCI paid membership dues on behalf of Susan Paresky the Sr. VP of Development, at the Harvard Club in Boston, MA. This positions responsibilities are those of fundraising. This membership provides use of space as well as important networking opportunities. The membership was utilized for business purposes, and therefoe was not included in taxable income. Part I Question 7 During the year, the CEO, COO, CFO, General Counsel, and the Key Employees were eligible to receive an incentive payment, a portion of which was a non-fixed payment payable at the discretion of the CEO and in the case of the CEO, the Board of Trustees, if the organization meets certain financial performance goals. The maximum possible non-fixed portion of these incentive payments ranged from 8% to 4% of base salary. Other reportable compensation includes current year vesting amounts in Dana-Farber Institute's Supplemental nonqualified retirement plan. Compensation for Karen Bird, Former Chief Financial Officer, is primarily derived from her work as Executive Director of the Alliance of Dedicated Cancer Centers (ADCC). The ADCC fully reimburses Dana-Farber Cancer Institute, Inc for her compensation and benefits related to her work at ADCC. The remainder of her compensation is derived from her work as a Senior Policy Advisor for Dana-Farber Cancer Institute, Inc. A Massachusetts Development Finance Agency 042456011 57586CZ24 2008-05-22 296490068 See Part VI false false false B Massachusetts Development Finance Agency 043431814 2012-07-02 57500000 See Part VI false false false C Massachusetts Development Finance Agency 043431814 2015-08-03 92500000 See Part VI false false false D Massachusetts Development Finance Agency 043431814 57584XNZ0 2016-06-23 281786480 See Part VI false false false A 150000000 0 302002059 8349259 4119476 0 2015100 116494 0 90335421 197066308 0 2011 true false true true B 0 0 57500000 0 0 0 0 0 0 0 57500000 0 2012 true false true true C 0 0 92500000 0 0 0 0 0 0 0 92500000 0 2015 true false true true D 0 0 282826011 0 1655104 0 2486701 0 0 302271959 0 0 false false true true A false false true true true true 0 false false false true B false false true true true true 0 false false false true C false false true true true true 0 false false false true D false false false true true 0 false false false true A false false false true true true Morgan Stanley Capit 39.8 false false true Trinity Funding 2.8 true false true B false false false true true true Morgan Stanley Capit 39.8 false false false 0 false true C false false false true true true Morgan Stanley Capit 39.8 false false false 0 false D false false false true false false 0 false 0 false true A true B true C true D true Part I (Bond Issues): A (a) Issuer name: Massachusetts Health and Educational Facilities Authority, succeeded by Massachusetts Development Finance Agency A (f) Description of purpose: The bond issue was used to refund Pool J-1 issued on June 30, 1993; Pool J-2 issued on June 8, 1995;Pool M-2 issued on May 30, 2002; Series H issued on May 4, 2004; Series I issued on February 8, 2007 to partially finance the construction of the Yawkey Center for Cancer Care. B (f) Description of purpose: The bond issue was used to refund part of Series L-2 bonds issued on 5/22/2008. C (f) Description of purpose: The bond issue was used to refund Series L-1 bonds issued on 5/22/2008. D (f) Description of purpose: The bond issue was / will be used to partially cover the acquisition and fit-out of research space and vivarium at the Longwood Center; to partially cover the replacement of HVAC system at the Smith Building; to cover the relocation to, reconstruction and equipping of the Institute's Cell Manipulation Core Facility; and to cover the costs of bond issuance and interest during the construction period as well as other capital projects. Part IV (Arbitrage): A 2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2017 B 2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2017 C 2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2017 D 2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2017 A 4(b) Name of provider: Morgan Stanley Capital Services, Inc. B 4(b) Name of provider: Morgan Stanley Capital Services, Inc. C 4(b) Name of provider: Morgan Stanley Capital Services, Inc. A 5(b) Name of provider: Trinity Funding Company, LLC Stephen Sallan Employee Tuition Assistance X 262081 60252 false true true Bruce Johnson Employee Housing Loan X 400000 28333 false true true Karen Bird Employee Tuition Assistance X 49550 21175 false true true Drew Memmott Employee Housing Loan X 75000 50625 false true true 160385 X 781250 Letter from Donor X 274 14846131 Fair Market Value X 42 405245 Letter from Donor X Miscellaneous 40 400269 Letter from Donor false true false Schedule M, Part I, Line 33 DFCI received donations of art, books, and other goods that it displays in its properties. These goods have values that are either nominal or are not readily determinable and are, therefore, not included as revenue. Part VI, Question 2 Family Relationship: John O'Connor and Laura Sen BUSINESS RELATIONSHIP: Richard Lubin, Christopher Hadley and Jane Brock-Wilson Business Relationship Part VI, Question 11 Process used to review the Form 990 The Form 990 is prepared by the Tax Department and independently reviewed by Ernst & Young, LLP for technical tax issues. After the Tax Department and Ernst & Young, LLP finalize the returns, The Chief Financial Officer of the Organization meets with the Tax Department to review the tax return And may direct additional changes. After the CFO approves the return, certain sections are taken to Board Committees for a more detailed analysis. For example, the Board Compensation Committee reviews all information related to compensation in Part VII and Schedule J. Once the return has been through the committees who review certain sections, the tax return is presented to the Audit Committee for review and approval. After the audit committee approves the tax return, an electronic message is sent to all Board members with a secure link to the tax return. The Board has the opportunity to review the return and they can bring any issues to the attention of the appropriate executive management individuals. A final version of the form is made available to the Board before filing with the IRS. The return is only filed after each of the steps in the review process has been completed. Part VI, Question 12c Monitoring & Enforcement of Conflict of Interest Policy. The Office of General Counsel, the Assistant Secretary of the Board, and the Tax Department draft a Conflict of Interest Disclosure Questionnaire each year and requires that all trustees, officers, and key employees fill out a questionnaire in order to identify potential disclosures for DFCI's returns. The Assistant Secretary compiles the list of Disclosures and gathers financial data from the Accounts Payable and Payroll Department for all organizations, employees, independent contractors, and other miscellaneous transactions which were disclosed by all individuals. Once all of this information is compiled, the Office of General Counsel and the Tax Department goes through each transaction and disclosure to determine what needs to be disclosed on the tax return. The Tax Department and the Office of General Counsel also discusses if there are any other known transactions that have not been disclosed. If there are any questions regarding such situation, the Office of General Counsel and the Assistant Secretary will discuss the questions with the individual trustees, oficers and key employees involved. In addition the process described above, the governance committee of the board of directors annually reviews any new conflict of interest disclosures and they address any issues that may arise. The governance committee is also responsible to bring any major issues related to the conflict of interest policy to the executive committee and the entire Board if deemed necessary. Per DFCI's conflict of interest policy, in order to avoid a conflict of interest or an appearance of a conflict of interest: 1. A Trustee should not participate in a vote on a transaction in which the Trustee or family member has a financial interest and should disclose any potential conflict before DFCI acts on the transaction. 2. A Trustee, a member of his or her family, or an entity with which one or more of them has a material interest, may not do business with DFCI unless expressly authorized by DFCI after full disclosure. 3. A Trustee should fully disclose his or her association (including employment, consulting, or membership on a governing board by the Trustee or a family member) with an entity that competes with or has interests conflicting with those of DFCI and should refrain from participating in any vote if the vote affects DFCI. Once a disclosure has been made, DFCI's Office of General Counsel reviews such conflict and may discuss the matter with the appropriate parties. The Office of General Counsel will then review the matter with the Chairman of the Board. Final decisions are made with the chairman and possibly the Board's Executive Committee. Part VI, Question 15a Process for determining compensation of President per DFCI's Executive Compensation Philosophy, annually the Compensation Committee of the Board of Trustees reviews the President's (DFCI's Chief Executive Officer) performance and makes a recommendation regarding compensation to the Executive Committee. The Executive Committee acts on the recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Executive Committee is reported to the full Board. Annually, following the filing of Form 990, DFCI compares the information it reports for its President to the compensation of Presidents/CEO's at other area healthcare organizations as well as other institutions that are considered designated comprehensive cancer centers. The Board completed this process as of June 2016. Part VI, Question 15b Process for determining compensation of officers and key employees Per DFCI's Executive Compensation Philosophy, annually the DFCI President reviews the performance of Officers and Key Employees and makes a recommendation as to their compensation to the Compensation Committee of the Board of Trustees. The Compensation Committee establishes compensation for those individuals based on that recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Compensation Committee is reported to the Executive Committee of the Board of Trustees and to the full Board. Annually, following the filing of Form 990s DFCI compares the compensation of these individuals with those at other area healthcare organizations as well as other institutions that are considered designated cancer centers. Part VI, Question 19 Availability of Governing Documents, Conflict of Interest Policy, and Financial Statements to the Public We currently provide the governing documents upon request. The Governing Documents are also available to the Public on the Secretary of the Commonwealth's website. Conflict of Interest Policy - DFCI's Conflict of Interest Policy can be found within its Code of Conduct, which is available on its website. Financial Statements - The organization uses the services of Digital Assurance Certification LLC (DAC) to report annual audited financial statements and other relevant organizational information as required by certain regulatory and tax laws. DAC is a website (www.dacbond.com) free to the public that publishes tax-exempt bond issuers' financial and legal documents such as the Audited Financial Statements. Fiscal Year 2001 through the latest issue date of the Audited Financial Statements for Dana-Farber Cancer Institute, Inc. can be found on the DAC website. PART XI LINE 9 OTHER CHANGES IN NET ASSETS CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATE $137,073,981 CHANGE IN VALUE OF SWAP AGREEMENT $15,997,227 PENSION ADJUSTMENT $3,757,053 Total Other Changes in Net Assets $156,828,261 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER FEES FOR SERVICE TOTAL FEES:XXX-XX-XXXX FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED RESEARCH SERVICES TOTAL FEES:47359697 FORM 990 PART IX LINE 11G DESCRIPTION:FOOD SERVICES TOTAL FEES:5068388 Dana-Farber Inc 450 Brookline Avenue BP418 BOSTON MA 02215 043102433 INVEST MGMT MA 501(c)(3) 12A, TYPE 1 DFCI true DANA-FARBER TRUST INC 450 Brookline Avenue BP418 BOSTON MA 02215 300195757 DFCI RE MGMT MA 501(c)(3) 12a DFCI true DANA-FARBER PARTNERS CANCER CARE INC 450 Brookline Avenue BP418 BOSTON MA 02215 043320640 ONCOL SUP ORG MA 501(c)(3) 12c FI DFCI false RMSA TRUST 450 Brookline Avenue BP418 BOSTON MA 02215 562656539 RETRMT TRUST MA 501(c)(9) DFCI true Friends of Dana-Farber Cancer Institute 450 Brookline Ave BP418 Boston MA 02215 371613621 Fundraising MA 501(c)(3) 12A, TYPE 1 DFCI true Dana-Farber Children's Hosp Cancer Care 450 Brookline Ave BP418 Boston MA 02215 043554536 Pediatric Onc MA 501(c)(3) Type 1 N/A Dana-Farber Cancer Care Network Inc 450 Brookline Avenue BP 418 Boston MA 02215 465138314 ONCOL SUP ORG MA 501(c)(3) Type 1 DFCI true DFPCC Ptshp 450 Brookline Avenue BP418 BOSTON MA 02215 043402364 ONCOLOGY PTNR MA related 0 0 false 0 0.50000 false true true false false false false false false false true false false true false false true true Dana-Farber Partners Cancer Care Inc O 34143 CASH Dana-Farber Partners Cancer Care Inc R 239800 CASH Dana-Farber Partners Cancer Care Inc L 43277018 CASH Dana-Farber Inc R 38369853 CASH Dana-Farber Inc S 228311677 CASH Friends of Dana-Farber Cancer Institute Inc O 262924 Actual Expense RMSA Trust R 176225 CASH Friends of Dana-Farber Cancer Institute Inc B 50000 Cash Friends of Dana-Farber Cancer Institute Inc C 515304 Cash Dana-Farber Cancer Care Network Inc M 34047683 cost Dana-Farber Cancer Care Network Inc R 42696727 cost Friends of Dana-Farber Cancer Institute Inc 12360 cost